Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
22 October 2021Website:
http://minervasurgical.comNext earnings report:
09 July 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Fri, 28 Jun 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
UTRS Latest News
Minerva Surgical (NASDAQ: UTRS ) stock is taking a beating on Monday after the women's healthcare company announced that its shares will be delisted later this month. According to a filing with the Securities and Exchange Commission (SEC), the company's shares will no longer trade on the Nasdaq Exchange starting on Dec. 29.
Minerva Surgical, Inc. (NASDAQ:UTRS ) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Caroline Corner - IR Todd Usen - President & CEO Joel Jung - CFO Conference Call Participants Operator Greetings, and welcome to the Minerva Surgical Q2 2023 Earnings Call. At this time all participants are in listen-only mode.
Minerva Surgical, Inc. (UTRS) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.20 per share a year ago.
Minerva Surgical (NASDAQ: UTRS ) stock is rising higher on Wednesday despite a lack of news from the surgical and medical instrument manufacturing company. There have been no new press releases or filings with the Securities and Exchange Commission (SEC) that would explain why shares of UTRS stock are rising today.
Minerva Surgical, Inc. (NASDAQ:UTRS ) Q1 2023 Earnings Conference Call May 2, 2023 4:30 PM ET Company Participants Caroline Corner - Investor Relations Todd Usen - President & CEO, Director Joel Jung - Chief Financial Officer Conference Call Participants Phillip Dantoin - Piper Sandler Operator Good day and thank you for standing by. Welcome to Minerva Surgical First Quarter 2023 Earnings Conference Call.
What type of business is Minerva Surgical?
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
What sector is Minerva Surgical in?
Minerva Surgical is in the Healthcare sector
What industry is Minerva Surgical in?
Minerva Surgical is in the Medical Devices industry
What country is Minerva Surgical from?
Minerva Surgical is headquartered in United States
When did Minerva Surgical go public?
Minerva Surgical initial public offering (IPO) was on 22 October 2021
What is Minerva Surgical website?
https://minervasurgical.com
Is Minerva Surgical in the S&P 500?
No, Minerva Surgical is not included in the S&P 500 index
Is Minerva Surgical in the NASDAQ 100?
No, Minerva Surgical is not included in the NASDAQ 100 index
Is Minerva Surgical in the Dow Jones?
No, Minerva Surgical is not included in the Dow Jones index
When does Minerva Surgical report earnings?
The next expected earnings date for Minerva Surgical is 09 July 2024